DR. KADE is a medium-sized German specialty pharmaceutical company based in Berlin and Constance. The company has been owned by one family for four generations and can look back on a tradition of 125 years.
The company specializes in manufacturing and marketing drugs in the fields of gynecology, proctology and pain/rheumatism. The potential of well-proven active pharmaceutical ingredients is systematically developed by galenic research and realized in innovative products. These processes make use of the latest findings in medicinal and pharmaceutical science. Based on intensive cooperation with competent partners abroad, our products are successfully marketed not only in Germany, but also in Asia, as well as Central and Eastern Europe.
DR. KADE has been the leading manufacturer of anti-hemorrhoidal products for many years with a market share of almost 30% in Germany, Japan and numerous other countries. Following a targeted expansion of its product range, the company also has a leading position in the field of gynecology. The success of DR. KADE is based primarily on the commitment of 400 employees. Their motivation and creativity are an essential prerequisite for meeting the high quality standards demanded by global competition. DR. KADE offers a strong target group sales force for gynecologist, pain specialists and pharmacies in Germany.
Dr. KADE is interested in the following opportunities:
- innovative or well established OTC-products,
- Rx products,
- late-stage development projects (phase III or later)
Main indication areas:
- urology / andrology
Dr. KADE offers:
1. Cliovelle® tablets
Low dose estradiol / norethisteronacetat oral combination product for continuous Hormone Replacement Therapy (HRT).
2. Posterisan® protect ointment and suppositories
Skin protector for the supportive treatment of hemorrhoid complaints. The product is certified as medical device in Europe (Class IIa).
3. DoloVisano® Methocarbamol 750 mg tablets
Centrally acting muscle relaxant for the treatment of painful muscle tensions.
4. Oekolp® ovula 0,03mg
Low dose estriol for the local treatment of vaginal estrogen deficiency symptoms.
Contraceptive, containing dienogest / ethinylestradiol.
Dr Christian Wagner
Head of Corporate Development
Clients in focus...